Lantheus Holdings (LNTH) Total Debt (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Total Debt came in at $570.4 million in Q1 2026, up 0.63% year-on-year from $566.8 million in Q1 2025, and little changed on a QoQ basis from $569.4 million in Q4 2025.
Lantheus Holdings (LNTH) Total Debt (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Total Debt data on file, last reported at $570.4 million in Q1 2026.
- On a quarterly basis, Total Debt rose 0.63% year-over-year to $570.4 million in Q1 2026; TTM through Mar 2026 was $570.4 million, a 0.63% increase from a year earlier, with the FY2025 full-year figure at $569.4 million, up 0.56% from the prior year.
- Total Debt for Q1 2026 stood at $570.4 million, roughly flat from $569.4 million in the prior quarter.
- Over the last five years, Total Debt for LNTH reached as high as $657.4 million in Q4 2022 and fell as low as $167.4 million in Q3 2022.
- Historically, Total Debt has averaged $500.7 million across 5 years, with a median of $564.1 million in 2024.
- Across the five-year window, Total Debt soared 276.17% in 2022 and slipped 14.44% in 2023, its largest moves.
- Year by year, Total Debt stood at $657.4 million in 2022, then declined by 14.44% to $562.5 million in 2023, then climbed by 0.67% to $566.3 million in 2024, then advanced by 0.56% to $569.4 million in 2025, then grew by 0.17% to $570.4 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $570.4 million in Q1 2026, $569.4 million in Q4 2025, and $568.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 570.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570.41 Mn |
| Dec 31, 2025 | 569.42 Mn |
| Sep 30, 2025 | 568.81 Mn |
| Jun 30, 2025 | 567.64 Mn |
| Mar 31, 2025 | 566.85 Mn |
| Dec 31, 2024 | 566.25 Mn |
| Sep 30, 2024 | 565.33 Mn |
| Jun 30, 2024 | 564.06 Mn |
| Mar 31, 2024 | 563.20 Mn |
| Dec 31, 2023 | 562.49 Mn |
| Sep 30, 2023 | 561.28 Mn |
| Jun 30, 2023 | 559.62 Mn |
| Mar 31, 2023 | 558.96 Mn |
| Dec 31, 2022 | 657.41 Mn |
| Sep 30, 2022 | 167.43 Mn |
| Jun 30, 2022 | 169.73 Mn |
| Mar 31, 2022 | 172.25 Mn |
| Dec 31, 2021 | 174.76 Mn |
| Sep 30, 2021 | 177.10 Mn |
| Jun 30, 2021 | 179.62 Mn |